Loopbaan van Harald Hechenberger
Eerdere bekende functies van Harald Hechenberger
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AlpenBank AG
AlpenBank AG Investment ManagersFinance Part of Alpen Privatbank AG, AlpenBank AG is an Austrian company that focuses on chronic heart disease called hypertrophic cardiomyopathy (HCM). Founded in 1983, the company is based in Innsbruck, Austria. HCM is a serious heart condition that affects the heart muscle, causing the walls of the heart to become thicker than they should be. This excessive thickening can cause the heart to become more stiff, leaving less room for blood to fill the heart. As a result, those with HCM may experience fatigue, a fast heartbeat, chest pain, breathing problems, or light-headedness which may interfere with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risk of atrial fibrillation (irregular heartbeat), stroke, heart failure, and in rare cases, sudden cardiac death. | Lid van de Investeringscommissie | 01-12-2001 | 11-01-2022 |
Portefeuillebeheerder-Aandelen | 01-12-2001 | 11-01-2022 |
Statistieken
Internationaal
Oostenrijk | 2 |
Operationeel
Investment Committee Member | 1 |
Portfolio Manager-Equities | 1 |
Sectoraal
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
AlpenBank AG
AlpenBank AG Investment ManagersFinance Part of Alpen Privatbank AG, AlpenBank AG is an Austrian company that focuses on chronic heart disease called hypertrophic cardiomyopathy (HCM). Founded in 1983, the company is based in Innsbruck, Austria. HCM is a serious heart condition that affects the heart muscle, causing the walls of the heart to become thicker than they should be. This excessive thickening can cause the heart to become more stiff, leaving less room for blood to fill the heart. As a result, those with HCM may experience fatigue, a fast heartbeat, chest pain, breathing problems, or light-headedness which may interfere with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risk of atrial fibrillation (irregular heartbeat), stroke, heart failure, and in rare cases, sudden cardiac death. | Finance |
- Beurs
- Insiders
- Harald Hechenberger
- Ervaring